Laboratoire Tilman has acquired Promogen
The shareholders of Promogen have sold the company to Laboratoire Tilman.
Founded in 1956, Laboratoire Tilman is a Belgium pharmaceutical laboratory specialized in the development, production and marketing of phytotherapy products and is the leader in the field of medicinal plants in Belgium. The company offers a range of more than 100 natural herbal solutions sold in over 30 countries, including best-selling products such as Flexofytol, Sedistress and Antimetil.
Founded in 2012, Promogen is an external independent French pharmaceutical network that promotes, sells and distributes a diverse portfolio, which includes medicines, medical devices, food supplements and cosmetics, through four brands, in the rheumatology, well-being, dermo-cosmetics, wound healing and fertility therapeutic areas. Promogen distributes its products to over 9,000 pharmacies and drugstores in France, through an in-house sales force of approximately 40 representatives.
Oaklins’ team in France acted as advisor to the shareholders of Laboratoire Tilman in this transaction.
Talk to the deal team
SulAmérica and Rede D’Or São Luiz have announced a combination
SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.Learn more
Dolmen Engineering has been acquired by NIRAS
The private shareholders of Dolmen Engineering have sold the company to NIRAS. The integration will enable the two companies to strengthen their positions within the European life science and food & beverage sectors and offer a fully integrated suite of services.Learn more
InMedica has acquired J. Pauliuko šeimos klinika
InMedica, the largest Lithuanian network of medical clinics, has acquired J. Pauliuko šeimos klinika.Learn more